Special Note on June 2022 Courses in San Diego
Learners have the option to register for the courses only—registration to the BIO International Convention is not required. If you are interested in the course-only registration option, please email BIO Customer Care for a course code. If you wish to register for BOTH the annual convention and any course offerings, visit the 2022 BIO International Convention registration website. See details on the variety of course options by scrolling down and clicking on the course description boxes below.
Explore a broad range of issues faced by entrepreneurs from the managerial, scientific, and academic communities...
Learn about the science driving today’s hottest biopharma innovations including CRISPR, CAR-T, gene therapy, and much more...
Enhance your skills in negotiations, influencing, decision-making, and game theory. Game theory will be applied to real-life pharma/biotech negotiation cases.
Learn from senior executives to expertly navigate transactional and intellectual property law; business development; finance...
Learn from experienced dealmakers a review of example models, a dissection of actual deals, have live participant interaction and Q&A opportunities.
Gain a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world...
What are the members of the promotional review team and why are these functional roles important for Medical, Legal and Regulatory (MLR) Review? Learn about MLR and more.
What are the three basic requirements for press releases? How do you know whether a press release is fairly balanced? Learn the FDA regs and more.
AAV Gene Therapy Manufacturing describes the properties of the naturally occurring Adeno-associated virus, discusses the use of this virus as a viral vector, and explains the manufacturing and control process including manufacturing platforms, vector characterization, and regulatory considerations.
Who are the FDA, OIG, PhRMA, AMA, and ACCME? Why do these organizations expect you to comply with their rules, codes, and...
NIH Recombinant DNA Compliance highlights the history and current legislative initiatives for NIH compliance, how these regulations may affect your institution and the operation of the Institutional Biosafety Committee.
Biomanufacturing introduces the intricacies and difficulties involved in manufacturing biologics. Biologics are produced in living cells, unlike small molecule drugs that are synthesized in glassware. To understand the biopharma industry, you need know how biologic medicines are produced. Biomanufacturing is for everyone in the biopharma industry, especially for those new to drug production, drug development or product launch.
OSHA Bloodborne Pathogens Regulations details current OSHA Bloodborne Pathogen Regulations, how to determine if your organization is subject to its laws, and how to properly integrate them into existing medical surveillance, health, and safety programs.
What are considered good publication practices for communicating company-sponsored medical research and how do these practices impact publication development and planning? Learn more in this pub planning module.
Learn from experienced dealmakers a review of example models, a dissection of actual deals, have live participant interaction and Q&A opportunities.
Enhance your skills in negotiations, influencing, decision-making, and game theory. Game theory will be applied to real-life pharma/biotech negotiation cases.
Learn about the science driving today’s hottest biopharma innovations including CRISPR, CAR-T, gene therapy, and much more...
Explore a broad range of issues faced by entrepreneurs from the managerial, scientific, and academic communities...
Learn from senior executives to expertly navigate transactional and intellectual property law; business development; finance...
Gain a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world...
